Brief: Theriva Biologics Announces Pricing Of $7.5 Million Public Offering
07/05/2025 14:47
Theriva Biologics Inc TOVX.A: THERIVA BIOLOGICS ANNOUNCES PRICING OF $7.5 MILLION PUBLIC OFFERING Source text: ID:nGNX7LKtfw Further company coverage: TOVX.A
Recent news on Theriva Biologics
See all newsTheriva Biologics Q2 net loss narrows on lower R&D costs, expenses
Brief: Theriva™ Biologics Announces Upcoming Presentation Of Additional Data From The Virage Phase 2B Clinical Trial Of Vcn-01 In Metastatic Pancreatic Cancer At Aacr 2026 Annual Meeting
Brief: Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications
Brief: Theriva Biologics Implements 32% Workforce Reduction - SEC Filing
Brief: Theriva™ Biologics Announces Presentation Of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial At Asco 2025